|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0011900,
umls-concept:C0017817,
umls-concept:C0034380,
umls-concept:C0043210,
umls-concept:C0332161,
umls-concept:C0332293,
umls-concept:C0392756,
umls-concept:C0600688,
umls-concept:C1140680,
umls-concept:C1274040
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-9-22
|
|
pubmed:abstractText |
Early clinical trials have suggested that glutathione (GSH) offers protection from the toxic effects of cisplatin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
569-73
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9261526-Adult,
pubmed-meshheading:9261526-Aged,
pubmed-meshheading:9261526-Antidotes,
pubmed-meshheading:9261526-Antineoplastic Agents,
pubmed-meshheading:9261526-Cisplatin,
pubmed-meshheading:9261526-Dose-Response Relationship, Drug,
pubmed-meshheading:9261526-Double-Blind Method,
pubmed-meshheading:9261526-Drug Administration Schedule,
pubmed-meshheading:9261526-Drug Interactions,
pubmed-meshheading:9261526-Female,
pubmed-meshheading:9261526-Glutathione,
pubmed-meshheading:9261526-Humans,
pubmed-meshheading:9261526-Middle Aged,
pubmed-meshheading:9261526-Ovarian Neoplasms,
pubmed-meshheading:9261526-Quality of Life
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.
|
|
pubmed:affiliation |
ICRF Medical Oncology Unit, Western General Hospital, Edinburgh, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
